FEI, Transvalor, KPN, Vilmorin & Cie, Vyv Group, Mgen and Clarins subsidiary Famille C were all among the contributors to the fund’s $82.3m close.
Author: Thierry Heles
UPMC Enterprises to deploy $1bn
University of Pittsburgh Medical Center’s investment and innovation arm has allocated $1bn to drug development funding over the next four years.
Soul Machines sources $40m
The avatar software provider has ramped up its series B round to $40m, adding Salesforce Ventures to a consortium that already included Daimler.
Isar Aerospace takes off with series A
Corporate venturing unit Airbus Ventures has co-led a $16.5m series A round for cost-efficient rocket developer Isar, which is preparing for its first launch in 2021.
Kandou connects to Swisscom for $56m series C
EPFL spinout Kandou has pushed its total funding to $96m in a series C round that included both Swisscom Ventures and Swisscom’s Digital Transformation Fund.
Exyn takes off with $16m
IUniversity of Pennsylvania spinout Exyn Technologies has completed a series A round backed by Yamaha Motor to accelerate the development of its AI drone software.
Thrive Earlier Detection arrives with $110m
Thrive will commercialise a blood test for multiple early-stage cancers based on research at Johns Hopkins University, following a series A round backed by Blue Cross and Blue Shield Association.
HTGF bags another investor for $375m close
The founders of backpack brand Fond Of have joined 32 corporate investors in High-Tech Gründerfonds’ third fund, which has now officially closed.
Pfizer feels its way to $340m Therachon acquisition
Therachon, which had raised $100m from investors including Pfizer Ventures and Novo, has agreed to be acquired by Pfizer in a deal that could potentially reach $810m.
Satsuma snatches $62m in series B round
Shin Nippon Biomedical Laboratories was among the investors in its spinoff, which is working on treatments for acute migraine.
Zapata zips to $21m
Comcast Ventures co-led a series A round for the quantum computing technology developer that included BASF Venture Capital and Robert Bosch Venture Capital.
Ola navigates $1bn round
Naspers and Temasek are discussing an investment of $1bn in Ola that would value the ride-sharing firm at $7bn to $8bn.
Oyo to accomodate $1bn
SoftBank Vision Fund has contributed to an initial $800m tranche, with more than half of the round allocated to Oyo’s expansion across China.
Certify sorts Captio acquisition
Expense management platform Captio has been acquired by Certify for an undisclosed sum, providing exits to Bankinter and Banco Sabadell.